Microvascular cox-2/mpges-1/ep-4 axis in human abdominal aortic aneurysm

Journal of Lipid Research

Volumn 54, Issue 12, 2013, Pages 3506-3515

  Camacho, Mercedes ^a   Dilmé, Jaume ^a   Solà Villà, David ^c   Rodríguez, Cristina ^b   Bellmunt, Sergi ^a   Siguero, Laura ^a   Alcolea, Sonia ^a   Romero, José María ^a   Escudero, José Román ^a   Martínez González, José ^b   Vila, Luis ^a  

^a BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^b Institut Català de Ciències Cardiovasculars   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Angiogenesis; Cyclooxygenase; Cyclooxygenase pathway; E prostanoid receptor; Microsomal isoform of prostaglandin E synthase; Prostaglandin

Indexed keywords

CD45 ANTIGEN; CYCLOOXYGENASE 2; ISOENZYME; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E SYNTHASE 1;

ABDOMINAL AORTA ANEURYSM; ADULT; ADVENTITIA; AGED; ANGIOGENESIS; ARTERY DIAMETER; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MICROSOME; MICROVASCULATURE; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; UPREGULATION; VASCULARIZATION;

ANGIOGENESIS; CYCLOOXYGENASE; CYCLOOXYGENASE PATHWAY; E PROSTANOID RECEPTOR; MICROSOMAL ISOFORM OF PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN;

AGED; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LEUKOCYTES; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE;

EID: 84887917930     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M042481     Document Type: Article

References (42)

1. Weintraub, N. L. 2009. Understanding abdominal aortic aneurysm. N. Engl. J. Med. 361:1114-1116.
2. Wahlgren, C. M., E. Larsson, P. K. E. Magnusson, R. Hultgren, and J. Swadenborg. 2010. Genetic and enviromental contributions to abdominal aortic aneurysm development in twin population. J. Vasc. Surg. 51:3-7.
3. Choke, E., G. Cockerill, W. R. Wilson, S. Sayed, J. Dawson, I. Loftus, and M. M. Thompson. 2005. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur. J. Vasc. Endovasc. Surg. 30:227-244. (Pubitemid 41086292)
4. Paik, D. C, C. Fu, J. Bhattacharya, and M. D. Tilson. 2004. Ongoing angiogenesis in blood vessels of the abdominal aortic aneurysm. Exp. Mol. Med. 36:524-533. (Pubitemid 40129174)
5. Choke, E., M. M. Thompson, J. Dawson, W. R. Wilson, S. Sayed, I. M. Loftus, and G W. Cockerill. 2006. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler. Thromb. Vasc. Biol. 26:2077-2082. (Pubitemid 44253791)
6. Vila, L. 2004. Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med. Res. Rev. 24:399-424. (Pubitemid 38802696)
7. Bishop-Bailey, D., J. A. Mitchell, and T. D. Warner. 2006. COX-2 in cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 26:956-958. (Pubitemid 43732096)
8. Solà-Villà, D., M. Camacho, R Solà, M. Soler, J. M. Diaz, and L. Vila. 2006. IL-1|3 induces VEGF, independently of PGE 2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells. Kidney Int. 70:1935-1941. (Pubitemid 44863381)
9. Camacho, M., E. Gerbolés, J. R. Escudero, R. Anton, X. García-Moll, and L. Vila. 2007. Microsomal-PGE synthase-1, which is not coupled to a particular COX-isoenzyme, is essential for PGE 2 biosynthesis in vascular smooth muscle cells. J. Thromb. Haemost. 5:1411-1419. (Pubitemid 46969879)
10. Soler, M., M. Camacho, J. R. Escudero, M. A. Iñiguez, and L. Vila. 2000. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ. Res. 87:504-507.
11. Salvado, M. D., A. Alfranca, A. Escolano, J. Haeggström, and J. M. Redondo. 2009. COX-2 limits prostanoid production in activated HUVECs and is a source of PGH 2 for transcellular metabolism to PGE 2 by tumor cells. Arterioscler. Thromb. Vasc. Biol. 29:1131-1137.
12. Holmes, D. R., W. Wester, R. W. Thompson, and J. M. Reilly. 1997. Prostaglandin E 2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms. J. Vasc. Surg. 25:810-815. (Pubitemid 27227676)
13. Walton, L. J., I. J. Franklin, T. Bayston, L. C. Brown, R. M. Greenhalgh, G. W. Taylor, and J. T. Powell. 1999. Inhibition of prostaglandin E 2 synthesis in abdominal aortic aneurysms. Implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation. 100:: 48-54. (Pubitemid 29297939)
14. King, V. L., D. B. Trivedi, J. M. Gitlin, and C. D. Loftin. 2006. Selective cyclooxygenase-2 inhibition with celecoxib decreases angiotensin II-induced abdominal aortic aneurysm formation in mice. Arterioscler. Thromb. Vasc. Biol. 26:1137-1143. (Pubitemid 43732124)
15. Gitlin, J. M., D. B. Trivedi, R. Langenbach, and C. D. Loftin. 2007. Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovasc. Res. 73:227-236. (Pubitemid 44937188)
16. Wang, M., E. Lee, W. Song, E. Ricciotti, D. J. Rader, J. A. Lawson, E. Puré, and G. A. FitzGerald. 2008. Microsomal prostaglandin E synthase-1 deletion suppresses oxidative stress and angiotensin II-induced abdominal aortic aneurysm formation. Circulation. 117:1302-1309. (Pubitemid 351365673)
17. Narumiya, S., Y. Sugimoto, and F. Ushikubi. 1999. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:1193-1226. (Pubitemid 29473315)
18. Tang, E. H., E. Shvartz, K. Shimizu, V. Z. Rocha, C. Zheng, D. Fukuda, G. P. Shi, G. Sukhova, and P. Libby. 2011. Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 31:261-269.
19. Cao, R. Y., T. St Amand, X. Li, S. H. Yoon, C. P. Wang, H. Song, T. Maruyama, P. M. Brown, D. T. Zelt, and C. D. Funk. 2012. Prostaglandin receptor EP4 in abdominal aortic aneurysms. Am. J. Pathol. 181:313-321.
20. Yokoyama, U., R. Ishiwata, M. H. Jin, Y. Kato, O. Suzuki, H. Jin, Y. Ichikawa, S. Kumagaya, Y. Katayama, T. Fujita, et al. 2012. Inhibition of EP4 signaling attenuates aortic aneurysm formation. PLoS ONE. 7:e36724.
21. Chapple, K. S., D. J. Parry, S. McKenzie, K. A. MacLennan, P. Jones, and D. J. Scott. 2007. Cyclooxygenase-2 expression and its association with increased angiogenesis in human abdominal aortic aneurysms. Ann. Vasc. Surg. 21:61-66. (Pubitemid 46228107)
22. Cheuk, B. L., and S. W. Cheng. 2007. Differential secretion of prostaglandin (E (2), thromboxane A (2) and interleukin-6 in intact and ruptured abdominal aortic aneurysm. Int. J. Mol. Med. 20:391-395.
23. Granström, E., M. Hamberg, G. Hansson, and H. Kindahl. 1980. Chemical instability of 15-keto-13, 14-dihydro-PGE2: the reason for low assay reliability. Prostaglandins. 19:933-957. (Pubitemid 10013224)
24. Bothwell, W., M. Verburg, M. Wynalda, E. G. Daniels, and F. A. Fitzpatrick. 1982. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics. J. Pharmacol. Exp. Ther. 220:229-235. (Pubitemid 12171972)
25. Brú, A., J. C. Souto, S. Alcolea, R. Antón, A. Remacha, M. Camacho, M. Soler, I. Brú, A. Porres, and L. Vila. 2009. Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based anti-tumour treatment. Mediators Inflamm. 2009:817498.
26. Casós, K., L. Siguero, M. T. Fernández-Figueras, X. León, M. P. Sardá, L. Vila, and M. Camacho. 2011. Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation. Microvasc. Res. 81:261-268.
27. Alfranca, A., J. M. López-Oliva, L. Genís, D. López-Maderuelo, I. Mirones, D. Salvado, A. J. Quesada, A. G. Arroyo, and J. M. Redondo. 2008. PGE 2 induces angiogenesis via MT1-MMP-mediated activation of the TGFbeta/Alk5 signaling pathway. Blood. 112:1120-1128.
28. Alcolea, S., R. Anton, M. Camacho, M. Soler, A. Alfranca, F. X. Aviles-Jurado, J. M. Redondo, M. Quer, X. Leon, and L. Vila. 2012. Interaction between head and neck squamous cell carcinoma (HNSCC) cells and fibroblasts in the biosynthesis of PGE 2. J. Lipid Res. 53:630-642.
29. McMillan, W. D., N. A. Tamarina, M. Cipollone, D. A. Johnson, M. A. Parcker, and W. H. Pearce. 1997. The relationship between MMP-9 expression and aortic diameter. Circulation. 96:2228-2232.
30. Herron, G. S., E. Unemori, M. Wong, J. H. Rapp, M. H. Hibbs, and R. J. Stoney. 1991. Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms. Arterioscler. Thromb. 11:1667-1677.
31. Nordon, I. M., R. J. Hinchliffe, I. M. Loftus, and M. M. Thompson. 2011. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat. Rev. Cardiol. 8:92-102.
32. Corcoran, M. L., W. G. Stetler-Stevenson, P. D. Brown, and L. M. Wahl. 1992. Interleukin 4 inhibition of prostaglandin E 2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267:515-519.
33. Varga, J., A. Diaz-Pérez, J. Rosenbloom, and S. A. Jimenez. 1987. PGE 2 causes a coordinate decrease in the steady state levels of fibronectin and types I and II procollagen mRNAs in normal dermal fibroblasts. Biochem. Biophys. Res. Commun. 147:1282-1288. (Pubitemid 17150598)
34. Camacho, M., J. López-Belmonte, and L. Vila. 1998. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and PGI-synthase activity. Circ. Res. 83:353-365. (Pubitemid 28389965)
35. Camacho, M., and L. Vila. 2000. Transcellular formation of thromboxane A 2 in mixed incubations of endothelial cells and aspirintreated platelets strongly depends on the prostaglandin I-synthase activity. Thromb. Res. 99:155-164. (Pubitemid 30628488)
36. Cattaneo, M. G., S. Pola, V. Dehò, A. M. Sanguini, and L. M. Vicentini. 2003. Alprostadil suppresses angiogenesis in vitro and in vivo in the murine Matrigel plug assay. Br. J. Pharmacol. 138:377-385. (Pubitemid 36188599)
37. Sennlaub, F., F. Valamanesh, A. Vazquez-Tello, A. M. El-Asrar, D. Checchin, S. Brault, F. Gobeil, M. H. Beauchamp, B. Mwaikambo, Y. Courtois, et al. 2003. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy. Circulation. 108:198-204. (Pubitemid 36871303)
38. Shoji, Y., M. Takahashi, T. Kitamura, K. Watanabe, T. Kawamori, T. Maruyama, Y. Sugimoto, M. Negishi, S. Narumiya, T. Sugimura, et al. 2004. Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development. Gut. 53:1151-1158. (Pubitemid 38961971)
39. Katoh, H., K. Hosono, Y. Ito, T. Suzuki, Y. Ogawa, H. Kubo, H. Kamata, T. Mishima, H. Tamaki, H. Sakagami, et al. 2010. COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems. Am. J. Pathol. 176:1469-1483.
40. Seno, H., M. Oshima, T. O. Ishikawa, H. Oshima, K. Takaku, T. Chiba, S. Narumiya, and M. M. Taketo. 2002. Cyclooxygenase 2- and prostaglandin E (2) receptor EP (2)-dependent angiogenesis in Apc (Delta716) mouse intestinal polyps. Cancer Res. 62:506-511. (Pubitemid 34110434)
41. Mutoh, M., K. Watanabe, T. Kitamura, Y. Shoji, M. Takahashi, T. Kawamori, K. Tani, M. Kobayashi, T. Maruyama, K. Kobayashi, et al. 2002. Involvement of prostaglandin E receptor subtype EP (4) in colon carcinogenesis. Cancer Res. 62:28-32. (Pubitemid 34073980)
42. Rao, R., R. Redha, I. Macias-Perez, Y. Su, C. Hao, R. Zent, M. D. Breyer, and A. Pozzi. 2007. Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J. Biol. Chem. 282:16959-16968. (Pubitemid 47093223)